New approaches to neuroprotection in infant heart surgery.
Advances in surgical techniques and perioperative management have led to dramatic improvements in outcomes for children with complex congenital heart disease (CHD). As the number of survivors continues to grow, clinicians are becoming increasingly aware that adverse neurodevelopmental outcomes after surgical repair of CHD represent a significant cause of morbidity, with widespread neuropsychologic deficits in as many as 50% of these children by the time they reach school age. Modifications of intraoperative management have yet to measurably impact long-term neurologic outcomes. However, exciting advances in our understanding of the underlying mechanisms of cellular injury and of the events that mediate endogenous cellular protection have provided a variety of new potential targets for the assessment, prevention, and treatment of neurologic injury in patients with CHD. In this review, we will discuss the unique challenges to developing neuroprotective strategies in children with CHD and consider how multisystem approaches to neuroprotection, such as ischemic preconditioning, will be the focus of ongoing efforts to develop new diagnostic tools and therapies. Although significant challenges remain, tremendous opportunity exists for the development of diagnostic and therapeutic interventions that can serve to limit neurologic injury and ultimately improve outcomes for infants and children with CHD.
Albers
Erin L
EL
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37323, USA.
Bichell
David P
DP
McLaughlin
Bethann
B
D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000266:history / Q000379:methods / Q000639:trends; D002490:Central Nervous System / Q000293:injuries*; D006330:Heart Defects, Congenital / Q000601:surgery*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019194:Ischemic Preconditioning; D018696:Neuroprotective Agents / Q000266:history / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology; D015398:Signal Transduction; D013997:Time Factors; D016896:Treatment Outcome
D018696:Neuroprotective Agents